Physician profile
Alexander Brown
NPI 1417376500
$18,092.10
in general payments reported to CMS, 2019-2025
23 companies · $1,067 in 2025
The $1,067 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10K · 2021: $1,369 · 2022: $2,747 · 2023: $555 · 2024: $2,124 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,948 · Travel and Lodging: $1,790 · Long Term Medical Supply Or Device Loan: $7.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,947.57 |
| Travel and Lodging | $1,790.40 |
| Long Term Medical Supply Or Device Loan | $7.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,260.84 | 2020 | |
| Alpha Orthopedic Systems | $4,030.56 | 2020-2022 | |
| Stryker Corporation | $3,130.32 | 2021-2024 | Mako, Cobra, Triathlon |
| Arthrex, INC. | $923.84 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $468.55 | 2020-2025 | Persona, Avenir, Comprehensive Shoulder System |
| Orthalign INC | $341.90 | 2023 | Orthalign Plus |
| Depuy Synthes Sales INC. | $268.62 | 2020-2022 | |
| Djo, LLC | $93.04 | 2025 | Donjoy |
| Glaxosmithkline, LLC. | $78.69 | 2023 | Arexvy, Shingrix, Fluarix Quadrivalent |
| Vertex Pharmaceuticals Incorporated | $77.23 | 2024-2025 | |
| Sandoz INC. | $67.09 | 2023-2024 | Hyrimoz |
| Radius Health, INC. | $59.77 | 2024-2025 | Tymlos |
| Ferring Pharmaceuticals INC. | $55.56 | 2024-2025 | Euflexxa |
| Amgen INC. | $49.58 | 2024 | Prolia, Evenity |
| Bioventus LLC | $38.31 | 2024-2025 | Exogen Ultrasound Bone Healing System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mf Med | $32.02 | 2025 | |
| Dynasplint Systems INC. | $21.19 | 2025 | Dynasplint |
| Vericel Corporation | $20.93 | 2025 | Maci |
| Bayer Healthcare Pharmaceuticals INC. | $18.66 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $17.91 | 2024 | Exparel, Zilretta |
| Solventum Corporation | $15.78 | 2025 | Prevena, V.A.C.Instill |
| Horizon Therapeutics Plc | $11.69 | 2020 | |
| Reprise Biomedical, INC. | $10.02 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.